Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
ANDREWS, P.W.; D. BAKER; N. BENVINISTY; B. MIRANDA; K. BRUCE et al.
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
Autoři
ANDREWS, P.W.; D. BAKER; N. BENVINISTY; B. MIRANDA; K. BRUCE; O. BRUSTLE; M. CHOI; Y.M. CHOI; J.M. CROOK; P.A. de SOUSA; Petr DVOŘÁK; C. FREUND; M. FIRPO; M.K. FURUE; P. GOKHALE; H.Y. HA; E. HAN; S. HAUPT; L. HEALY; D.J. HEI; O. HOVATTA; C. HUNT; S.M. HWANG; M.S. INAMDAR; R.M. ISASI; M. JACONI; V. JEKERLE; P. KAMTHORN; M.C. KIBBEY; I. KNEZEVIC; B.B. KNOWLES; S.K. KOO; Y. LAABI; L. LEOPOLDO; P. LIU; G.P. LOMAX; J.F. LORING; T.E. LUDWIG; K. MONTGOMERY; C. MUMMERY; A. NAGY; Y. NAKAMURA; N. NAKATSUJI; S. OH; S.K. OH; T. OTONKOSKI; M. PERA; M. PESCHANSKI; P. PRANKE; K.M. RAJALA; M. RAO; R. RUTTACHUK; B. REUBINOFF; L. RICCO; H. ROOKE; D. SIPP; G.N. STACEY; H. SUEMORI; T.A. TAKAHASHI; K. TAKADA; S. TALIB; S. TANNENBAUM; B.Z. YUAN; F. ZENG a Q. ZHOU
Vydání
REGENERATIVE MEDICINE, LONDON, FUTURE MEDICINE LTD, 2015, 1746-0751
In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribution of human embryonic stem cell (hESC) lines for research purposes [1], which was broadly also applicable to human induced pluripotent stem cell (hiPSC) lines. Here, we revisit this guidance to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications. The term ‘seed stock’ is used here to describe those cryopreserved stocks of cells established early in the passage history of a pluripotent stem cell line in the lab that derived the line or a stem cell bank, hereafter called the ‘repository’.
ANDREWS, P.W.; D. BAKER; N. BENVINISTY; B. MIRANDA; K. BRUCE; O. BRUSTLE; M. CHOI; Y.M. CHOI; J.M. CROOK; P.A. de SOUSA; Petr DVOŘÁK; C. FREUND; M. FIRPO; M.K. FURUE; P. GOKHALE; H.Y. HA; E. HAN; S. HAUPT; L. HEALY; D.J. HEI; O. HOVATTA; C. HUNT; S.M. HWANG; M.S. INAMDAR; R.M. ISASI; M. JACONI; V. JEKERLE; P. KAMTHORN; M.C. KIBBEY; I. KNEZEVIC; B.B. KNOWLES; S.K. KOO; Y. LAABI; L. LEOPOLDO; P. LIU; G.P. LOMAX; J.F. LORING; T.E. LUDWIG; K. MONTGOMERY; C. MUMMERY; A. NAGY; Y. NAKAMURA; N. NAKATSUJI; S. OH; S.K. OH; T. OTONKOSKI; M. PERA; M. PESCHANSKI; P. PRANKE; K.M. RAJALA; M. RAO; R. RUTTACHUK; B. REUBINOFF; L. RICCO; H. ROOKE; D. SIPP; G.N. STACEY; H. SUEMORI; T.A. TAKAHASHI; K. TAKADA; S. TALIB; S. TANNENBAUM; B.Z. YUAN; F. ZENG a Q. ZHOU. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). REGENERATIVE MEDICINE. LONDON: FUTURE MEDICINE LTD, 2015, roč. 10, č. 2, s. 1-44. ISSN 1746-0751. Dostupné z: https://doi.org/10.2217/RME.14.93.
@article{1307860, author = {Andrews, P.W. and Baker, D. and Benvinisty, N. and Miranda, B. and Bruce, K. and Brustle, O. and Choi, M. and Choi, Y.M. and Crook, J.M. and Sousa, P.A. de and Dvořák, Petr and Freund, C. and Firpo, M. and Furue, M.K. and Gokhale, P. and Ha, H.Y. and Han, E. and Haupt, S. and Healy, L. and Hei, D.J. and Hovatta, O. and Hunt, C. and Hwang, S.M. and Inamdar, M.S. and Isasi, R.M. and Jaconi, M. and Jekerle, V. and Kamthorn, P. and Kibbey, M.C. and Knezevic, I. and Knowles, B.B. and Koo, S.K. and Laabi, Y. and Leopoldo, L. and Liu, P. and Lomax, G.P. and Loring, J.F. and Ludwig, T.E. and Montgomery, K. and Mummery, C. and Nagy, A. and Nakamura, Y. and Nakatsuji, N. and Oh, S. and Oh, S.K. and Otonkoski, T. and Pera, M. and Peschanski, M. and Pranke, P. and Rajala, K.M. and Rao, M. and Ruttachuk, R. and Reubinoff, B. and Ricco, L. and Rooke, H. and Sipp, D. and Stacey, G.N. and Suemori, H. and Takahashi, T.A. and Takada, K. and Talib, S. and Tannenbaum, S. and Yuan, B.Z. and Zeng, F. and Zhou, Q.}, article_location = {LONDON}, article_number = {2}, doi = {https://doi.org/10.2217/RME.14.93}, keywords = {COPY NUMBER; MOLECULAR CYTOGENETICS; GENOMIC STABILITY; GENE-EXPRESSION; LINES; CULTURE; CRYOPRESERVATION; MUTATIONS; TERATOCARCINOMAS; STANDARDIZATION}, language = {eng}, issn = {1746-0751}, journal = {REGENERATIVE MEDICINE}, title = {Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)}, volume = {10}, year = {2015} }
TY - JOUR ID - 1307860 AU - Andrews, P.W. - Baker, D. - Benvinisty, N. - Miranda, B. - Bruce, K. - Brustle, O. - Choi, M. - Choi, Y.M. - Crook, J.M. - Sousa, P.A. de - Dvořák, Petr - Freund, C. - Firpo, M. - Furue, M.K. - Gokhale, P. - Ha, H.Y. - Han, E. - Haupt, S. - Healy, L. - Hei, D.J. - Hovatta, O. - Hunt, C. - Hwang, S.M. - Inamdar, M.S. - Isasi, R.M. - Jaconi, M. - Jekerle, V. - Kamthorn, P. - Kibbey, M.C. - Knezevic, I. - Knowles, B.B. - Koo, S.K. - Laabi, Y. - Leopoldo, L. - Liu, P. - Lomax, G.P. - Loring, J.F. - Ludwig, T.E. - Montgomery, K. - Mummery, C. - Nagy, A. - Nakamura, Y. - Nakatsuji, N. - Oh, S. - Oh, S.K. - Otonkoski, T. - Pera, M. - Peschanski, M. - Pranke, P. - Rajala, K.M. - Rao, M. - Ruttachuk, R. - Reubinoff, B. - Ricco, L. - Rooke, H. - Sipp, D. - Stacey, G.N. - Suemori, H. - Takahashi, T.A. - Takada, K. - Talib, S. - Tannenbaum, S. - Yuan, B.Z. - Zeng, F. - Zhou, Q. PY - 2015 TI - Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI) JF - REGENERATIVE MEDICINE VL - 10 IS - 2 SP - 1-44 EP - 1-44 PB - FUTURE MEDICINE LTD SN - 17460751 KW - COPY NUMBER KW - MOLECULAR CYTOGENETICS KW - GENOMIC STABILITY KW - GENE-EXPRESSION KW - LINES KW - CULTURE KW - CRYOPRESERVATION KW - MUTATIONS KW - TERATOCARCINOMAS KW - STANDARDIZATION N2 - In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribution of human embryonic stem cell (hESC) lines for research purposes [1], which was broadly also applicable to human induced pluripotent stem cell (hiPSC) lines. Here, we revisit this guidance to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications. The term ‘seed stock’ is used here to describe those cryopreserved stocks of cells established early in the passage history of a pluripotent stem cell line in the lab that derived the line or a stem cell bank, hereafter called the ‘repository’. ER -
ANDREWS, P.W.; D. BAKER; N. BENVINISTY; B. MIRANDA; K. BRUCE; O. BRUSTLE; M. CHOI; Y.M. CHOI; J.M. CROOK; P.A. de SOUSA; Petr DVOŘÁK; C. FREUND; M. FIRPO; M.K. FURUE; P. GOKHALE; H.Y. HA; E. HAN; S. HAUPT; L. HEALY; D.J. HEI; O. HOVATTA; C. HUNT; S.M. HWANG; M.S. INAMDAR; R.M. ISASI; M. JACONI; V. JEKERLE; P. KAMTHORN; M.C. KIBBEY; I. KNEZEVIC; B.B. KNOWLES; S.K. KOO; Y. LAABI; L. LEOPOLDO; P. LIU; G.P. LOMAX; J.F. LORING; T.E. LUDWIG; K. MONTGOMERY; C. MUMMERY; A. NAGY; Y. NAKAMURA; N. NAKATSUJI; S. OH; S.K. OH; T. OTONKOSKI; M. PERA; M. PESCHANSKI; P. PRANKE; K.M. RAJALA; M. RAO; R. RUTTACHUK; B. REUBINOFF; L. RICCO; H. ROOKE; D. SIPP; G.N. STACEY; H. SUEMORI; T.A. TAKAHASHI; K. TAKADA; S. TALIB; S. TANNENBAUM; B.Z. YUAN; F. ZENG a Q. ZHOU. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). \textit{REGENERATIVE MEDICINE}. LONDON: FUTURE MEDICINE LTD, 2015, roč.~10, č.~2, s.~1-44. ISSN~1746-0751. Dostupné z: https://doi.org/10.2217/RME.14.93.